Cell Therapy and Transplantation in Parkinsons Disease
Identifieur interne : 001B00 ( Main/Exploration ); précédent : 001A99; suivant : 001B01Cell Therapy and Transplantation in Parkinsons Disease
Auteurs : Olle Lindvall ; Peter HagellSource :
- Clinical Chemistry and Laboratory Medicine [ 1434-6621 ] ; 2001-04-25.
Abstract
Transplanted human fetal dopamine neurons can reinnervate the striatum in patients with Parkinson's disease (PD). Recent findings using positron emission tomography indicate that the grafts are functionally integrated and restore dopamine release in the patient's striatum. The grafts can exhibit long-term survival without immunological rejection and despite an ongoing disease process and continuous antiparkinsonian drug treatment. In the most successful cases, patients have been able to withdraw L-dopa treatment after transplantation and resume an independent life. About two-thirds of grafted patients have shown clinically useful, partial recovery of motor function. The major obstacle for the further development of this cell replacement strategy is that large amounts of human fetal mesencephalic tissue are needed for therapeutic effects. Stem cells hold promise as a virtually unlimited source of self-renewing progenitors for transplantation. The possibility to generate dopamine neurons from such cells is now being explored using different approaches. However, so far the generated neurons have survived poorly after transplantation in animals.
Url:
DOI: 10.1515/CCLM.2001.056
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cell Therapy and Transplantation in Parkinsons Disease</title><author><name sortKey="Lindvall, Olle" sort="Lindvall, Olle" uniqKey="Lindvall O" first="Olle" last="Lindvall">Olle Lindvall</name></author><author><name sortKey="Hagell, Peter" sort="Hagell, Peter" uniqKey="Hagell P" first="Peter" last="Hagell">Peter Hagell</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:13F085FCD5D5822B6712E7A2CD88E5D7E5E36222</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1515/CCLM.2001.056</idno><idno type="url">https://api.istex.fr/document/13F085FCD5D5822B6712E7A2CD88E5D7E5E36222/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002462</idno><idno type="wicri:Area/Main/Curation">002134</idno><idno type="wicri:Area/Main/Exploration">001B00</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Cell Therapy and Transplantation in Parkinsons Disease</title><author><name sortKey="Lindvall, Olle" sort="Lindvall, Olle" uniqKey="Lindvall O" first="Olle" last="Lindvall">Olle Lindvall</name></author><author><name sortKey="Hagell, Peter" sort="Hagell, Peter" uniqKey="Hagell P" first="Peter" last="Hagell">Peter Hagell</name></author></analytic><monogr></monogr><series><title level="j">Clinical Chemistry and Laboratory Medicine</title><title level="j" type="abbrev">Clinical Chemistry and Laboratory Medicine</title><idno type="ISSN">1434-6621</idno><imprint><publisher>Walter de Gruyter</publisher><date type="published" when="2001-04-25">2001-04-25</date><biblScope unit="volume">39</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="356">356</biblScope><biblScope unit="page" to="361">361</biblScope></imprint><idno type="ISSN">1434-6621</idno></series><idno type="istex">13F085FCD5D5822B6712E7A2CD88E5D7E5E36222</idno><idno type="DOI">10.1515/CCLM.2001.056</idno><idno type="ArticleID">cclm.39.4.356</idno><idno type="Related-article-Href">cclm.2001.056.pdf</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1434-6621</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Transplanted human fetal dopamine neurons can reinnervate the striatum in patients with Parkinson's disease (PD). Recent findings using positron emission tomography indicate that the grafts are functionally integrated and restore dopamine release in the patient's striatum. The grafts can exhibit long-term survival without immunological rejection and despite an ongoing disease process and continuous antiparkinsonian drug treatment. In the most successful cases, patients have been able to withdraw L-dopa treatment after transplantation and resume an independent life. About two-thirds of grafted patients have shown clinically useful, partial recovery of motor function. The major obstacle for the further development of this cell replacement strategy is that large amounts of human fetal mesencephalic tissue are needed for therapeutic effects. Stem cells hold promise as a virtually unlimited source of self-renewing progenitors for transplantation. The possibility to generate dopamine neurons from such cells is now being explored using different approaches. However, so far the generated neurons have survived poorly after transplantation in animals.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Hagell, Peter" sort="Hagell, Peter" uniqKey="Hagell P" first="Peter" last="Hagell">Peter Hagell</name><name sortKey="Lindvall, Olle" sort="Lindvall, Olle" uniqKey="Lindvall O" first="Olle" last="Lindvall">Olle Lindvall</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B00 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B00 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:13F085FCD5D5822B6712E7A2CD88E5D7E5E36222
|texte= Cell Therapy and Transplantation in Parkinsons Disease
}}
| This area was generated with Dilib version V0.6.23. |  |